INS and myocardial ischemia: In diabetic mice, it was shown that treatment with OSM alleviated cardiac ischemia/reperfusion injury through inhibition of cardiomyocyte apoptosis and enhancement of mitochondrial biogenesis and mitochondrial function, while an adverse outcome followed by impairment of insulin sensitivity was demonstrated in OSM receptor knockout diabetic mice [39].